Vitrolife Q4’2020: Very strong Numbers.

Research Note

2021-02-10

08:46

Redeye's first impression of the fourth-quarter report. Sales amounted to SEK 382, a decrease of 7% in SEK. Thus, very much in line with our expected SEK 378m. The Covid-19 continues to affect sales, but there is a clear business return and not as harsh as earlier. EBIT was also considerably higher than we and the street expected at SEK 147m vs. our expected SEK 121m. (Estimated consensus SEK 129m).

MH

Mats Hyttinge

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.